Melanoma
Not Melanoma
Technical
Potpourri
100

When do you need SLNB

T1b

-> anything greater than 0.8mm OR ulceration

100

Nivolumab/pembrolizumab MOA

PD-1 monoclonal antibodies

100

What separates the superficial and deep inguinal nodes?

Fascia lata

100

Best imaging modality for soft tissue sarcoma/tumor

MRI

200

Melanoma T staging (& Margins)

Tis (0.5-1cm)

T1 < 1 mm (1cm)

T2 1-2 (1-2cm)

T3 2-4 (2cm)

T4 >4 (2cm)

b = ulceration

200

Most common cancer in transplant patients?

Non-melanoma skin cancer

200

What is cloquet's node?

The upper most deep inguinal node under the inguinal ligment, last stop before the external iliac nodes - sort of a SLN

200

Method of spread of sarcoma

hematogenous

300

Major MSLT - I Findings

-Doubling of melanoma-specific survival in intermediate thickness melanomas compared to WLE alone

-SLN independently associated with prognosis

-Note: all patients with + node underwent CLND

300

Treatment of SCC of the nose, lip, eyelid

XRT alone

300

Appropriate extremity sarcoma biopsy techniques

Core needle biopsy

<5 cm excisional biopsy

> 5 cm incisional biopsy, longitudinal incision over scar (encompass in WLE later)

300

Most common benign salivary gland tumor / treatment

Pleomorphic adenoma / superficial parotidectomy

400

Major DeCOG-SLT Findings

Pts with + SLN randomized to obs vs CLND

-Underpowered

-equivalent survival between CLND/ultrasound with obs

-Set stage for MSLTII

400

Treatment for merkel cell cancer

neuroendocrine tumor of the dermis

WLE with 2cm margins, XRT to excision site and regional nodes 

High locoregional recurrence

400

Which tracer can be used for SLNB in pregnancy?

radiolabeled colloid (can't use isosulfan blue)

400

Benefits of full thickness skin grafting

-Increased primary contraction with decreased secondary contraction

-Better color matching (face)

-better for joint coverage (trauma-resistant)

500

Major MSLT II Findings

Randomized to CLND vs US/Obs, appropriate power

-No difference in melanoma specific survival, small advantage of CLND in disease-free survival but 24% lymphedema (vs 6)

-No groups with benefit from CLND

-US every 4-6 months for 5 years

500

Most common malignant salivary tumor / treatment 

mucoepidermoid

Low grade - total parotid

High grade - total parotid, neck dissection

500

When to perform a deep inguinal node dissection?

Positive cloquet node

> 4 positive superficial nodes

Palpable matted nodes

500

Most common site of unknown primary SCC

ipsilateral tonsil

M
e
n
u